Abstract:It is of great interest to develop strategic methods to enable chemicals' metabolites to be accurately and rapidly screened and identified. To screen and identify a category of metabolites with distinct isotopic distribution, this study proposed a generic strategy using in silico metabolite prediction plus accurate-mass-based isotopic pattern recognition (AMBIPR) and library identification on the data acquired via the data dependent MS/MS scan of LC-Q Exactive Orbitrap mass spectrometry. The proposed method was evaluated by the analysis of flurochloridone (FLC) metabolites in rat urine sample collected from toxicity tests. Different from the traditional isotopic pattern recognition (IPR) approach, AMBIPR here was performed based on the potential metabolites predicted via in silico metabolite prediction tools. Thus, the AMBIPR treated FLC data was only associated with FLC metabolites, consequently not only avoiding great efforts made to remove FLC-unrelated information and reveal FLC metabolites, but also increasing the percent of positive hits. Among the FLC metabolite peaks screened using AMBIPR, 87% of them (corresponding 97 metabolites and 49 biotransformation) were successfully identified via multiple MS identification techniques packaged in an established FLC's metabolites library based on Mass Frontier. Noteworthy, 34 metabolites (89%) were identified without distinct naturally isotopic distribution. The universal strategic approach based on background subtraction (BS) and mass defect filtering (MDF) was used to evaluate the AMBIPR and no more false positive and negative metabolites were detected. Furthermore, our results revealed that AMBIPR is very effective, inherently sensitive and accurate, and is easily automated for the rapidly screening and profiling chemicals related metabolites.

Analysis of hydrochloride 4-methyl-piperazine-1-carbodithioc acid 3-cyano-3,3-diphenyl-propyl ester and its metabolites in rats by HPLC-ESI/ITMSn]

Analysis of 4-Methyl-piperazine-1-carbodithioic Acid 3-Cyano-3,3-diphenyl-propyl Ester Hydrochloride and Its Major Metabolites in Rat Plasma and Tissues by LC-MS/MS.

Studies on the Metabolism of 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3,3-diphenylpropyl Ester Hydrochloride in Rats by High-Performance Liquid Chromatography/electrospray Ionization Tandem Mass Spectrometry

Simultaneous Determination of 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3,3-diphenylpropyl Ester Hydrochloride and Its Major Metabolite in Rats by Hplc

Studies on the Metabolism of 4-Methylpiperazine-1-carbodithioc Acid 3-Cyano-3,3- Diphenylpropyl Ester Hydrochloride in Rat Bile by High-Performance Liquid Chromatography/electrospray Ionization Tandem Mass Spectrometry.

Metabonomic Analysis of the Toxic Effects of TM208 in Rat Urine by HPLC-ESI-IT-TOF/MS.

Determination of Anti-Tumor Agent TM208, 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3,3-diphenylpropyl Ester Hydrochloride, in Rats by LC

LC and LC–MS Study of the Bioavailability and Metabolites of TM208 after Oral and Intravenous Administration to Rat

A High-Sensitivity Lc-Ms/Ms Method for the Determination of 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3, 3-Diphenylpropyl Ester Hydrochloride in Rat Plasma and Its Application to A Pharmacokinetics Study

Determination of 4-Methylpiperaine-1-carbodithioc Acid 3-Cyano-3,3-diphenylpropyl Ester Hydrochloride in Rats' Plasma by Online-Spe-Hplc-Dad: Application to A Pharmacokinetic Study

Identification of Metabolites of Crude and Processed Fructus Corni in Rats by Microdialysis Sampling Coupled with Electrospray Ionization Linear Quadrupole Ion Trap Mass Spectrometry.

RP-HPLC DETERMINATION OF DIPHENYTRIAZOL IN RAT LIVER MICROSOMAL INCUBATES AND ITS APPLICATION IN IN VITRO METABOLISM

Preparation and Rats' Pharmacokinetics of TM208 HP-β-CD Inclusion Complexes

Identification of the metabolite and cytochrome P450 isoenzymes involved in the rat liver microsomal metabolism of TM208

Characterization of the herb-derived components in rats following oral administration of Carthamus tinctorius extract by extracting diagnostic fragment ions (DFIs) in the MS(n) chromatograms.

Identification of Flurochloridone Metabolites in Rat Urine Using Liquid Chromatography/high Resolution Mass Spectrometry.

[Metabolite identification of isochlorogenic acid A in rats by HPLC-Q-Exactive Orbitrap-MS]

Rapid screening and identification of metabolites of murpanicin in rats by UHPLC/Q-TOF-MS/MS combined with diagnostic fragment ions (DFIs) and multiple mass defect filter

[Identification of Metabolites in Rat Plasma,bile,urine and Feces after Oral Administration of Cinnamomi Cortex Aqueous Extract by UPLC-Qtrap-MS].

Simultaneous quantification of icaritin and its novel 3-methylcarbamate prodrug in rat plasma using HPLC-MS/MS and its application to pharmacokinetic study

Metabolic analysis of four phenolic acids in rat by liquid chromatography-tandem mass spectrometry.